Berlin – Germany, 2024-03-22

Historic decision: The Cannabis Legalization Act was passed without a mediation committee

The German Federal Council (Bundesrat) approved the Cannabis Act in its session on March 22, 2024. Requests for convening the Mediation Committee did not receive a majority.

Legal possession and consumption of limited amounts

The law provides for a partial legalization of cannabis. It allows for the possession of up to 25 grams, up to 50 grams within one’s own four walls. Additionally, the cultivation of three cannabis plants in one’s own apartment becomes legal, with the harvested cannabis intended solely for personal use and not for distribution.

For more information, see the following Source:
Federal Council – 1042nd meeting on 22.03.2024

PR-Contact for Natural Pharma

Dr. Daniel König
+49 (0) 2173 940 95 91

About Natural Pharma

Natural Pharma Resource (Natural Pharma) GmbH was founded at the beginning of 2022 and is based in Langenfeld, Germany.

The pharmaceutical and biotechnological company focuses on the import, storage, manufacturing, distribution and export of pharmaceutical products, preparations and substances, in particular medicinal products under the German Medicines Act (AMG), narcotics under the German Narcotics Act (BtMG) and cannabis for medicinal purposes as well as research and development in this field.

We are licensed pharmaceutical wholesalers according to § 52a of the German Medicines Act (AMG) and have a permit to handle narcotics according to § 3 of the Federal Institute for Drugs and Medical Devices (BtMG).

For more information, visit: Natural Pharma

Our Philosophie

The company philosophy of Natural Pharma is simple. The goal is to provide patients with high quality natural and medicinal products, especially those made from cannabis plants.
Natural Pharma Resource GmbH is committed to selecting manufacturers that take into account important patient welfare criteria in order to provide an additional therapeutic option for patients with previously unsatisfactory therapeutic outcomes.
The company’s own products, partner products and also targeted products of German competitors will be offered via the Natural Pharma sales platform.

Business partner

Become our partner and actively participate with your resources in the German cannabis market. With our in-depth understanding of the German cannabis market and our extensive experience in natural pharma, we provide you with a secure and profitable investment opportunity.

Internal forwarding: Press “Partnership” button please